Cargando…
Peptide–nanoparticle conjugates: a next generation of diagnostic and therapeutic platforms?
Peptide–nanoparticle conjugates (PNCs) have recently emerged as a versatile tool for biomedical applications. Synergism between the two promising classes of materials allows enhanced control over their biological behaviors, overcoming intrinsic limitations of the individual materials. Over the past...
Autores principales: | Jeong, Woo-jin, Bu, Jiyoon, Kubiatowicz, Luke J., Chen, Stephanie S., Kim, YoungSoo, Hong, Seungpyo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289934/ https://www.ncbi.nlm.nih.gov/pubmed/30539365 http://dx.doi.org/10.1186/s40580-018-0170-1 |
Ejemplares similares
-
Hierarchically Multivalent Peptide–Nanoparticle Architectures: A Systematic Approach to Engineer Surface Adhesion
por: Jeong, Woo‐jin, et al.
Publicado: (2021) -
Machine-Learning-Based Clinical Biomarker Using Cell-Free DNA for Hepatocellular Carcinoma (HCC)
por: Lee, Taehee, et al.
Publicado: (2022) -
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics
por: Jeong, Hyomin, et al.
Publicado: (2022) -
siRNA Conjugated Nanoparticles—A Next Generation Strategy to Treat Lung Cancer
por: Itani, Rasha, et al.
Publicado: (2019) -
Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer
por: Bu, Jiyoon, et al.
Publicado: (2020)